2018-24969. Proposed Data Collection Submitted for Public Comment and Recommendations  

  • Start Preamble

    AGENCY:

    Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

    ACTION:

    Notice with comment period.

    SUMMARY:

    The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Emerging Infections Program (EIP). The EIP is a population-based surveillance activity performed via active, laboratory case finding that is used for detecting, identifying, and monitoring emerging pathogens.

    DATES:

    CDC must receive written comments on or before January 14, 2019.

    ADDRESSES:

    You may submit comments, identified by Docket No. CDC-2018-0098 by any of the following methods:

    • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments.
    • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS-D74, Atlanta, Georgia 30329.

    Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to Regulations.gov.

    Please note: Submit all comments through the Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the address listed above.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below.

    The OMB is particularly interested in comments that will help:

    1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;

    2. Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;

    3. Enhance the quality, utility, and clarity of the information to be collected; and

    4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses.

    5. Assess information collection costs.

    Proposed Project

    Emerging Infections Program OMB# 0920-0978 Exp. Date: 05/31/2021—Revision—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).

    Background and Brief Description

    The Emerging Infections Programs (EIPs) are population-based centers of excellence established through a network of state health departments collaborating with academic institutions; local health departments; public health and clinical laboratories; infection control professionals; and healthcare providers. EIPs assist in local, state, and national efforts to prevent, control, and monitor the public health impact of infectious diseases.

    Activities of the EIPs fall into the following general categories: (1) Active surveillance; (2) applied public health epidemiologic and laboratory activities; (3) implementation and evaluation of Start Printed Page 57489pilot prevention/intervention projects; and (4) flexible response to public health emergencies. Activities of the EIPs are designed to: (1) Address issues that the EIP network is particularly suited to investigate; (2) maintain sufficient flexibility for emergency response and new problems as they arise; (3) develop and evaluate public health interventions to inform public health policy and treatment guidelines; (4) incorporate training as a key function; and (5) prioritize projects that lead directly to the prevention of disease.

    A revision is being submitted to make existing collection instruments clearer and to add several new forms specifically surveying laboratory practices. These forms will allow the EIP to better detect, identify, track changes in laboratory testing methodology, gather information about laboratory utilization in the EIP catchment area to ensure that all cases are being captured, and survey EIP staff to evaluate program quality.

    The total estimated burden is 40,601 hours. There is no cost to respondents other than their time.

    Estimated Annualized Burden Hours

    Type of respondentForm nameNumber of respondentsNumber of responses per respondentAvg. burden per response (in hours)Total burden (in hours)
    State Health DepartmentABCs Case Report Form1080920/602697
    ABCs Invasive Pneumococcal Disease in Children Case Report Form102210/6037
    ABCs H.influenzae Neonatal Sepsis Expanded Surveillance Form10610/6010
    ABCs Severe GAS Infection Supplemental Form1013620/60453
    ABCs Neonatal Infection Expanded Tracking Form103720/60123
    FoodNet Campylobacter1094221/603297
    FoodNet Cyclospora1016310/60272
    FoodNet Listeria monocytogenes101520/6050
    FoodNet Salmonella1078921/602761
    FoodNet Shiga toxin producing E. coli1020520/60683
    FoodNet Shigella1021310/60355
    FoodNet Vibrio103410/6056
    FoodNet Yersinia104810/6080
    FoodNet Hemolytic Uremic Syndrome Case Report Form10101100
    FoodNet Clinical Laboratory Practices and Testing Volume—NEW107020/60233
    Influenza Hospitalization Surveillance Network Case Report Form10100025/604167
    Influenza Hospitalization Surveillance Project Vaccination Phone Script Consent Form (English/Spanish)103335/60278
    Influenza Hospitalization Surveillance Project Vaccination Phone Script (English/Spanish)103335/60278
    Influenza Hospitalization Surveillance Project Provider Vaccination History Fax Form (Children/Adults)103335/60278
    FluSurv-NET Laboratory Survey—NEW102310/6038
    HAIC CDI Case Report Form10165035/609625
    HAIC CDI Annual Laboratory Survey—NEW101610/6027
    HAIC CDI Annual Surveillance Officers Survey—NEW10115/603
    HAIC CDI LTCF Survey—NEW10455/6038
    HAIC Multi-site Gram-Negative Bacilli Case Report Form (MuGSI-CRE/CRAB)1050025/602083
    HAIC Multi-site Gram-Negative Surveillance Initiative—Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (MuGSI-ESBL)10120025/605000
    HAIC Invasive Methicillin-resistant Staphylococcus aureus (MRSA)1047425/601975
    HAIC Invasive Methicillin-sensitive Staphylococcus aureus (MSSA)1075425/603142
    HAIC Invasive Staphylococcus aureus Annual Laboratory Survey—NEW10118/6015
    HAIC Invasive Staphylococcus aureus Annual Surveillance Officers Survey—NEW10110/602
    HAIC Candidemia Case Report Form980020/602400
    HAIC Candidemia Periodic Laboratory Survey—NEW91520/6045
    Total40,601
    Start Signature
    Start Printed Page 57490

    Jeffrey M. Zirger,

    Acting Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention.

    End Signature End Supplemental Information

    [FR Doc. 2018-24969 Filed 11-14-18; 8:45 am]

    BILLING CODE 4163-18-P

Document Information

Published:
11/15/2018
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Action:
Notice with comment period.
Document Number:
2018-24969
Dates:
CDC must receive written comments on or before January 14, 2019.
Pages:
57488-57490 (3 pages)
Docket Numbers:
60 Day-19-0978, Docket No. CDC-2018-0098
PDF File:
2018-24969.pdf